ACB News & Events

Latest data shows the largest indicative borrow rate increases among liquid option names include: Euro ETF (FXE) 8.63% +2.14, DXC Technology (DXC) 2.17% +1.67, MSOX ETF (MSOX) 12.96% +0.78, Avis Budget (CAR) 1.90% +0.73, T-REX 2X Long BMNR Daily Target ETF (BMNU) 23.23% +0.57, Aurora Cannabis (ACB) 4.53% +0.55, Proshares Bitcoin ETF (BITO) 1.23% +0.42, Klarna Group PLC (KLAR) 2.65% +0.40, NovaDel Pharma (NVDL) 4.77% +0.24, and APP Pharmaceuticals, Inc (APPX) 5.81% +0.20.

Aurora Cannabis is expanding its Aurora medical portfolio in Australia and New Zealand, delivering patients and prescribers enhanced choice, reliable quality, and easier access to science-backed products. The expansion underscores the company's ongoing dedication to meeting the unique needs of patients and healthcare professionals in the region, reflecting Aurora's strategic focus on long-term global growth. The expansion in New Zealand this month includes two new THC flower products - Big Wave, Night Ride, as well as the balanced strain, Half Moon coming soon in Q1 FY27. The brand will also debut four new resin cartridges in Australia this month including, Chemango Kush, Cosmic Cream, Lunar Express, and Soul Train Haze.

Aurora Cannabis announced that it has filed a prospectus supplement establishing a new at-the-market offering program that allows the company to issue and sell up to $100M of common shares in the capital of the company from treasury to the public, from time to time, at the company's discretion.